Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19

This report describes a case of a male infant diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who was prescribed favipiravir therapy. The mother noticed a discoloration of the child's eyes within 18 h of therapy, and the cornea returned to normal color with...

Full description

Bibliographic Details
Main Authors: Paveewan Jiravisitkul, Saraiorn Thonginnetra, Rintra Wongvisavavit
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1154814/full
_version_ 1827964618618699776
author Paveewan Jiravisitkul
Saraiorn Thonginnetra
Rintra Wongvisavavit
author_facet Paveewan Jiravisitkul
Saraiorn Thonginnetra
Rintra Wongvisavavit
author_sort Paveewan Jiravisitkul
collection DOAJ
description This report describes a case of a male infant diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who was prescribed favipiravir therapy. The mother noticed a discoloration of the child's eyes within 18 h of therapy, and the cornea returned to normal color within 5 days of medication cessation. This case report highlights the need for monitoring of favipiravir therapy in children due to the potential side effect of corneal discoloration, which has not yet had its long-term effects identified.
first_indexed 2024-04-09T17:19:22Z
format Article
id doaj.art-685b9526f88f4e459f5848aa6051b100
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-09T17:19:22Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-685b9526f88f4e459f5848aa6051b1002023-04-19T04:39:54ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-04-011110.3389/fped.2023.11548141154814Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19Paveewan Jiravisitkul0Saraiorn Thonginnetra1Rintra Wongvisavavit2Department of Pediatrics, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, ThailandDepartment of Pediatrics, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, ThailandPrincess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, ThailandThis report describes a case of a male infant diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who was prescribed favipiravir therapy. The mother noticed a discoloration of the child's eyes within 18 h of therapy, and the cornea returned to normal color within 5 days of medication cessation. This case report highlights the need for monitoring of favipiravir therapy in children due to the potential side effect of corneal discoloration, which has not yet had its long-term effects identified.https://www.frontiersin.org/articles/10.3389/fped.2023.1154814/fullCOVID-19favipiravirbluish discolorationcorneainfantcase report
spellingShingle Paveewan Jiravisitkul
Saraiorn Thonginnetra
Rintra Wongvisavavit
Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
Frontiers in Pediatrics
COVID-19
favipiravir
bluish discoloration
cornea
infant
case report
title Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_full Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_fullStr Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_full_unstemmed Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_short Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
title_sort case report favipiravir induced bluish corneal discoloration in infant with covid 19
topic COVID-19
favipiravir
bluish discoloration
cornea
infant
case report
url https://www.frontiersin.org/articles/10.3389/fped.2023.1154814/full
work_keys_str_mv AT paveewanjiravisitkul casereportfavipiravirinducedbluishcornealdiscolorationininfantwithcovid19
AT saraiornthonginnetra casereportfavipiravirinducedbluishcornealdiscolorationininfantwithcovid19
AT rintrawongvisavavit casereportfavipiravirinducedbluishcornealdiscolorationininfantwithcovid19